Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Babban Lymphoma na B-cell (DLBCL)

Suna: Ba a bayar ba

Jinsi: Mace

Shekaru: Kusan shekaru 80

Ƙasa: Ba a bayar ba

Ganewar asali: Babban Lymphoma na B-cell (DLBCL)

    Majinyaciyar, mace mai juriya wacce ke da shekaru kusan 80, ta fuskanci gwajin cutar Diffuse Large B-cell Lymphoma (DLBCL) cikin ƙarfin hali, tana nuna ƙarfin hali a yaƙinta da wannan nau'in ciwon daji mai tsanani.

    Duk da tsufanta, ta ci gaba da ƙudurin shawo kan ƙalubalen da yanayinta ya haifar. Duk da haka, cikin watanni shida bayan ta sami sauƙi ta hanyar maganin farko, ta fuskanci koma-baya, wanda ke nuna yanayin tsananin cutarta. Duk da ƙoƙarin da aka yi sau da yawa na maganin na biyu da na uku, ciwon dajinta ya nuna juriya mai tsauri, wanda hakan ya zama babban ƙalubale ga ƙungiyar likitocinta.

    Da suka fahimci muhimmancin halin da take ciki, ƙungiyar likitocin ta fara wani bincike na neman hanyoyin magance wasu hanyoyin magancewa. An shigar da majinyaciyar cikin wani gwaji na asibiti da ke binciken maganin ƙwayoyin cuta na CD19+22 CAR-T, wata hanya ta zamani da ke amfani da ƙwayoyin T da aka ƙera ta hanyar halitta don kai hari ga ƙwayoyin cutar kansa da ke bayyana takamaiman ƙwayoyin cuta.

    Sakamakon ya kasance abin mamaki. Wata guda kacal bayan an saka ƙwayoyin CAR-T na CD19+22, majiyyaciyar ta sami cikakkiyar sauƙi. Wannan sakamako mai ban mamaki ba wai kawai ya dakatar da ci gaban cutar ba ne, har ma ya haifar da nasarar kawar da ƙwayoyin cutar kansa, wanda hakan ya nuna muhimmin lokaci a tafiyarta ta magani.

    A duk tsawon wannan aiki mai wahala, ƙungiyar likitoci ta ba da tallafi da kulawa mai ƙarfi ga majiyyaci. Tun daga sa ido sosai kan yadda take amsawa ga magani zuwa ga duk wani mummunan lamari, sun tabbatar da cewa lafiyarta ta kasance babban fifiko.

    Da take tunani game da abin da ya faru da ita, majiyyaciyar ta nuna matuƙar godiya ga kulawar tausayi da aka ba ta. "Sadaukarwa da ƙwarewar ƙungiyar likitoci na sun kasance abin ban mamaki," in ji ta. "Hanyar da suka bi wajen kula da lafiya ta musamman ta ba ni bege a lokacin da nake buƙatarta sosai."

    Nasarar da aka samu wajen maganin ƙwayoyin CD19+22 CAR-T wajen samun cikakkiyar sassauci ta nuna yuwuwarta a matsayin wata hanya mai kyau ta magani ga marasa lafiya da ke fama da cutar DLBCL. Wannan lamari ya zama shaida ga ƙarfin hanyoyin magani masu inganci da kuma magunguna na musamman wajen sarrafa cututtukan daji masu rikitarwa, musamman ga tsofaffi marasa lafiya kamar wannan mace mai ƙarfin hali.

    SHARI'A (14)omv

    Kafin & wata 1 bayan allurar

    bayanin2

    Submit An Free Inquiry

    Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

    AI Helps Write